Skip to content

Author

D. Kang

We have 2 of 117 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease

Lower baseline C3 was consistently associated with ARIA risk across sensitivity analyses and higher baseline C1q with smaller amyloid reduction at week 26, and this association persisted in international normalized ratio (INR)‐adjusted and simplified models.

Gihwan Byeon, Jung-Won Lee, Suhyung Kim et al. · 0 citations
Open access Sep 2026

748. Tau Pathology Modulates the Association Between Neurodegeneration and Depressive Symptoms in Alzheimer’s Disease

The findings indicate that the relationship between neurodegeneration and depression is stage-dependent and substantially modulated by tau pathology, and the importance of considering both proteopathic stage and preserved insight when interpreting affective symptoms across the Alzheimer’s disease continuum.

J.-W. Lee, D. Kang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.